SUNNYVALE, Calif., Dec. 23, 2024 (GLOBE NEWSWIRE) -- Ceribell, Inc. (Nasdaq: CBLL) (“Ceribell”), a medical technology company focused on transforming the diagnosis and management of patients ...

View CeriBell, Inc. (CBLL) current and estimated P/E ratio data provided by Seeking Alpha. Price/Earnings Ratio 2024 Estimated, using the consensus earnings estimate ...

Are you ready to innovate in the heart of Silicon Valley? We're looking for creative minds to drive advancements in AI-powered neurodiagnostics. Join our dynamic R&D team and shape the future of ...

Stalker 2: Heart of Chornobyl features a huge variety of artifacts with varying benefits and downsides, all having unique designs that make them distinct from each other. Among all the artifacts ...

2024年12月26日， CeriBell（CBLL）披露1笔公司内部人交易情况。高管Blumberg Scott于2024年12月23日买入1000股。 2024年12月26日 高管 Blumberg Scott 2024年12月23日 买入 1000 2.26 2260.00 2024年10月17日 持股10%以上股东 TPG GP A, LLC 2024年10月15日 买入 38.03万 ...

Two thieves donned diving gear to pilfer hundreds of ancient Greek and Roman artifacts from the bottom of the sea in Egypt, according to the country’s interior ministry. Egyptian authorities say ...

Meanwhile, a new trio of biotech companies’ shares came to market on Friday as Upstream Bio, Ceribell and Camp4 Therapeutics each made their public debut. In mid-September, Bicara Therapeutics ...